Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.

John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.